MetLife Investment Management’s indie Semiconductor INDI Stock Holding History
Bought
Maintained
Sold
Other funds holding INDI
ECP
MetLife Investment Management's INDI Position: Q2 2026 in Review
MetLife Investment Management increased its indie Semiconductor (INDI) stake by 39% in Q2 2026, buying an estimated $142K and bringing the position to 127,540 shares worth $573K. The position accounts for ﹤0.01% of the portfolio, ranked #1835.
MetLife Investment Management first reported a position in INDI in Q2 2022 and has held it in 17 quarters since. The position peaked at $689K in Q2 2023. 218 funds tracked by Wall St. Rank hold INDI as of Q2 2026.
- MetLife Investment Management held 127,540 shares of indie Semiconductor worth $573K as of Q2 2026.
- MetLife Investment Management bought 35,502 indie Semiconductor shares in Q2 2026, an estimated $142K.
- indie Semiconductor made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #1835 holding.
- MetLife Investment Management first reported a position in indie Semiconductor in Q2 2022 and has held it in 17 quarters since.
- MetLife Investment Management's indie Semiconductor position peaked at $689K in Q2 2023.
- 218 funds tracked by Wall St. Rank held indie Semiconductor as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.